Material Agreements

FLYEXCLUSIVE INC. amended A&R Merger Agreement with Jet.AI Inc. and Jet.AI SpinCo, Inc. (effective 2026-01-13).

“On January 13, 2026, the parties to the A&R Merger Agreement, as amended, executed Amendment No. 3 to the A&R Merger Agreement, as amended, to extend the Outside Date from December 31, 2025 to April 30, 2026 (“Amendment No. 3”).”

AirJoule Technologies Corp. entered into Underwriting Agreement with Lucid Capital Markets, LLC valued at approximately $19.3 million (effective 2026-01-14).

“On January 14, 2026, AirJoule Technologies Corporation (the “Company”) and Lucid Capital Markets, LLC, as underwriter (the “Underwriter”), entered into an underwriting agreement (the “Underwriting Agreement”), pursuant to which the Company agreed to sell to the Underwriter, and the Underwriter agreed to purchase from the Company, subject to and upon the terms and conditions set forth therein, 6,153,847 shares of its Class A common stock, par value $0.0001 per share (the “Class A Common Stock”) at the public offering price less underwriting discounts and commissions (the “Offering”).”

Rainmaker Worldwide Inc. entered into Settlement Agreement and Mutual Release with Sphere 3D Corp. valued at $500,000 (effective 2026-01-13).

“On January 13, 2026, Rainmaker Worldwide Inc. (the “Company”) entered into a Settlement Agreement and Mutual Release (the “Settlement Agreement”) with Sphere 3D Corp. (the “Holder”).”

Vocodia Holdings Corp entered into Securities Purchase and Share Exchange Agreement with WEB3 REX INC and its shareholders (effective 2026-01-13).

“On January 13, 2026 (the “Effective Date”), Vocodia Holdings Corp (“Vocodia” or the “Company”) entered into a Securities Purchase and Share Exchange Agreement (the “Agreement”) with WEB3 REX INC, a Wyoming corporation (“WEB3 REX”), and the shareholders of WEB3 REX (the “Sellers”).”

High Roller Technologies, Inc. entered into LOI with Foris DAX Markets, Inc. (FDMI) (effective 2026-01-12).

“On January 12, 2026, High Roller Technologies, Inc. (the “Company”) entered into a binding letter of intent (the “LOI”) with Foris DAX Markets, Inc. (“FDMI”) relating to a proposed strategic partnership involving derivatives contracts based on the outcome of specific and identifiable events in the “Predictions” product class offered by the North American Derivatives Exchange, Inc. d/b/a Crypto.com | Derivatives North America (“CDNA”), a subsidiary of FDMI.”

Nexscient, Inc. entered into Stock Purchase Agreement with Arcadia Data Pte. Ltd., Crestview BPO Pte. Ltd., Flipside Digital Content Company, Inc., and the selling shareholders named therein valued at $6,184,500 (effective 2026-01-13).

“On January 13, 2026, Nexscient, Inc., a Delaware corporation (the “Company”), entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Arcadia Data Pte. Ltd., Crestview BPO Pte. Ltd., Flipside Digital Content Company, Inc., and the selling shareholders named therein, pursuant to which the Company agreed to acquire 100% of the issued and outstanding equity interests of Crestview BPO Pte. Ltd.”

Six Flags Entertainment Corporation/NEW entered into Indenture with U.S. Bank Trust Company, National Association valued at $1,000,000,000 aggregate principal amount of 8.625% senior notes due 2032 (effective 2026-01-14).

“On January 14, 2026, Six Flags Entertainment Corporation (the “Company,” “we,” “us” or “Six Flags”), Canada’s Wonderland Company (“Cedar Canada”) and Millennium Operations LLC (“Millennium Operations” and, together with Cedar Canada, the “Subsidiary Co-Issuers” and, together with Six Flags and Cedar Canada, the “Co-Issuers”) closed its previously announced private offering (the “Offering”) of $1,000,000,000 aggregate principal amount of 8.625% senior notes due 2032 (the “Notes”) in transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”).”

Innventure, Inc. entered into Placement Agency Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC valued at 7.0% of aggregate proceeds as cash fee; expense reimbursement up to $100,000 (effective 2026-01-12).

“On January 12, 2026, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “Placement Agent”), as the sole placement agent in connection with the Offering.”

Innventure, Inc. entered into Securities Purchase Agreement with the purchasers party thereto valued at 11,428,572 shares of common stock at $0.0001 par value (effective 2026-01-12).

“on January 12, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers party thereto (the “Purchasers”).”

CLEARONE INC entered into Settlement Agreement and Waiver of Claims with eight former employees of ClearOne Spain, SL valued at aggregate cash payment of €392,809.80 (effective 2026-01-05).

“On January 5, 2026, ClearOne Spain entered into a Settlement Agreement and Waiver of Claims with the eight former employees (the “Settlement Agreement”). Under the terms of the Settlement Agreement, all eight former employees of ClearOne Spain agreed to dismiss and terminate all of their claims under the Spanish Proceeding in exchange for an aggregate cash payment from ClearOne Spain of €392,809.80.”

SYPRIS SOLUTIONS INC amended January 2026 Promissory Note with Gill Family Capital Management, Inc. (effective 2026-01-12).

“On January 12, 2026, Sypris Solutions, Inc. (the “Company”) and certain of its subsidiaries amended and restated its Amended and Restated Promissory Note dated March 21, 2025 (the “March 2025 Promissory Note”) in favor of Gill Family Capital Management, Inc., an entity controlled by the Company’s president and chief executive officer, Jeffrey T. Gill and one of its directors, R. Scott Gill (the “January 2026 Promissory Note”).”

LXP Industrial Trust amended Third Amended and Restated Credit Agreement with KeyBank National Association valued at $600.0 million senior unsecured revolving credit facility, or the Revolver, and (2) unsecured term l (effective 2026-01-13).

“On January 13, 2026, LXP Industrial Trust, or the Trust, amended and restated its existing credit agreement, which we refer to as the Third Amended and Restated Credit Agreement, among the Trust, as borrower, each of the financial institutions initially a signatory thereto together with their assignees pursuant to Section 12.5 therein, and KeyBank National Association, or KeyBank, as agent.”

Energy Transfer LP entered into Underwriting Agreement with BofA Securities, Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC, MUFG Securities Americas Inc. and SMBC Nikko Securities America, Inc. (effective 2026-01-12).

“On January 12, 2026, Energy Transfer LP (the “Partnership”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC, MUFG Securities Americas Inc. and SMBC Nikko Securities America, Inc., as joint book-running managers and representatives of the several underwriters named therein (collectively, the “Underwriters”), with respect to the public offering (the “Offering”) by the Partnership of $1,000,000,000 aggregate principal amount of its 4.550% Senior Notes due 2031 (the “2031 Notes”), $1,000,000,000 aggregate principal amount of its 5.350% Senior Notes due 2036 (the “2036 Notes”) and $1,000,000,000 aggregate principal amount of its 6.300% Senior Notes due 2056 (the “2056 Notes” and, together with the 2031 Notes and the 2036 Notes, the “Notes”).”

Scorpius Holdings, Inc. entered into Fourth Note with Holder valued at Principal $62,300.00, interest 5.0% per annum, premium 15% (effective 2026-01-08).

“On January 8, 2026, the Company issued a non-convertible promissory note (the “Fourth Note”) in the principal amount of Sixty-two Thousand and Three Hundred Dollars ($62,300.00) to the Holder.”

Scorpius Holdings, Inc. entered into Third Note with Holder valued at Principal $54,514.92, interest 5.0% per annum, premium 15% (effective 2025-12-30).

“On December 30, 2025, the Company issued a non-convertible promissory note (the “Third Note”) in the principal amount of Fifty-four Thousand Five Hundred and Fourteen Dollars and Ninety-two Cents ($54,514.92) to the Holder.”

Scorpius Holdings, Inc. entered into Second Note with Holder valued at Principal $78,350.00, interest 5.0% per annum, premium 15% (effective 2025-12-17).

“On December 17, 2025, the Company issued a non-convertible promissory note (the “Second Note”) in the principal amount of Seventy-eight Thousand and Three Hundred and Fifty Dollars ($78,350.00) to the Holder.”

Scorpius Holdings, Inc. entered into First Note with Holder valued at Principal $44,374.85, interest 5.0% per annum, premium 15% (effective 2025-12-16).

“On December 16, 2025, Scorpius Holdings, Inc. (the “Company”) issued a non-convertible promissory note (the “First Note”) in the principal amount of Forty-four Thousand Three Hundred Seventy-four Dollars and Eighty-five Cents ($44,374.85) to an institutional investor (the “Holder”).”

Clearway Energy, Inc. entered into Indenture with CSC Delaware Trust Company valued at $600 million aggregate principal amount of 5.750% senior notes due 2034 (effective 2026-01-13).

“Clearway Energy Operating LLC (“Clearway Operating”), a subsidiary of Clearway Energy, Inc., completed the sale of $600 million aggregate principal amount of 5.750% senior notes due 2034 (the “Senior Notes”) pursuant to the terms of the purchase agreement, dated January 8, 2026 (the “Purchase Agreement”), among Clearway Operating, the guarantors named therein and the initial purchasers named therein (the “Initial Purchasers”).”

SKYX Platforms Corp. entered into Purchase Agreement with a new strategic investor valued at $4,000,000 (effective 2026-01-07).

“On January 13, 2026, SKYX Platforms Corp. (the “Company”) reported that it entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a new strategic investor.”

AI Era Corp. entered into Securities Purchase Agreement with Vanquish Funding Group Inc. valued at $232,000 (effective 2026-01-09).

“On January 9, 2026, AI Era Corp. (the “Company”) entered into a Securities Purchase Agreement (the “SPA”) with Vanquish Funding Group Inc. (the “Lender”), pursuant to which the Company issued to the Lender a Convertible Promissory Note (the “Note”) in the principal amount of $232,000.”

Lifeward Ltd. entered into Share Purchase Agreement with Oramed Pharmaceuticals, Inc. (effective 2026-01-12).

“On January 12, 2026, Lifeward Ltd. (the “Company,” “we” or “us”) entered into a Share Purchase Agreement (“Share Purchase Agreement”) with Oramed Pharmaceuticals, Inc. (“Oramed”) and Oratech Pharma, Inc. (“Oratech”) pursuant to which the Company agreed to acquire all of the outstanding equity interests in Oratech, a wholly owned subsidiary of Oramed (the “Oratech Share Purchase”).”

Clearway Energy LLC entered into Indenture with CSC Delaware Trust Company (formerly known as Delaware Trust Company), as trustee (effective 2026-01-13).

“The Senior Notes were issued under an Indenture, dated January 13, 2026 (the “Indenture”), among Clearway Operating, the guarantors named therein and CSC Delaware Trust Company (formerly known as Delaware Trust Company), as trustee”

Clearway Energy LLC entered into Purchase Agreement with the initial purchasers named therein valued at $600 million aggregate principal amount (effective 2026-01-08).

“Clearway Energy Operating LLC (“Clearway Operating”), a subsidiary of Clearway Energy LLC, completed the sale of $600 million aggregate principal amount of 5.750% senior notes due 2034 (the “Senior Notes”) pursuant to the terms of the purchase agreement, dated January 8, 2026 (the “Purchase Agreement”), among Clearway Operating, the guarantors named therein and the initial purchasers named therein”

AMERICAN REBEL HOLDINGS INC entered into Exchange and Settlement Agreement with Agile Capital Funding, LLC valued at Exchanged all amounts due under Loan Agreement for 30,240 shares of Series D Convertible Preferred S (effective 2026-01-12).

“On January 12, 2026, (the “Closing Date”), the Company entered into an Exchange and Settlement Agreement (the “Securities Exchange Agreement”) with Agile Capital Funding, LLC (“Agile”). The Company previously entered into that certain Business Loan and Security Agreement (the “Loan Agreement”), pursuant to which Agile extended a term loan to the Company in an original principal amount of $787,500 dated December 4, 2025. Pursuant to the Securities Exchange Agreement, AREB and Agile exchanged all amounts due pursuant to the Loan Agreement for 30,240 shares of the Company’s Series D Convertible Preferred Stoc (the “Conversion Shares”), valued at $7.50 per share.”

AMERICAN REBEL HOLDINGS INC amended Amendment to Settlement Agreement and Stipulation with Silverback Capital Corporation valued at Lowered Floor Price for conversions to $0.51 per share (effective 2026-01-07).

“On January 7, 2026, the Company entered into an Amendment to Settlement Agreement and Stipulation (the “Amendment”) with Silverback Capital Corporation (“SCC”), which amended that certain Settlement Agreement and Stipulation dated as of October 28, 2025 (the “Settlement Agreement”). Pursuant to the Amendment, the Company and SCC agreed to lower the Floor Price for conversions, as defined in Paragraph 9 of the Settlement Agreement, to $0.51 per share.”

AMERICAN REBEL HOLDINGS INC entered into Second Exchange Agreement with Streeterville Capital, LLC valued at Exchange of Secured Promissory Note original principal $125,000 for 282,485 shares of common stock (effective 2026-01-13).

“On January 13, 2026, the Company and Streeterville entered into a second Exchange Agreement (the “Second Exchange”), whereby the Company and Streeterville agreed to partition a new Secured Promissory Note in the original principal amount of $125,000.00 (the “Second Partitioned Note”) from the Note and then cause the outstanding balance of the Note to be reduced by an amount equal to the initial outstanding balance of the Second Partitioned Note. Concurrently, the Second Partitioned Note was exchanged for 282,485 shares of the Company’s common stock.”

AMERICAN REBEL HOLDINGS INC entered into Exchange Agreement with Streeterville Capital, LLC valued at Exchange of Secured Promissory Note original principal $100,000 for 197,122 shares of common stock (effective 2026-01-06).

“On January 6, 2026, the Company entered into an Exchange Agreement (the “Exchange”) with Streeterville Capital, LLC (“Streeterville”). The Company previously entered into that certain Secured Promissory Note (the “Note”), with an original issuance date of June 26, 2025 in the principal amount of $5,470,000. Pursuant to the Exchange, the Company and Streeterville agreed to partition a new Secured Promissory Note in the original principal amount of $100,000.00 (the “Partitioned Note”) from the Note and then cause the outstanding balance of the Note to be reduced by an amount equal to the initial outstanding balance of the Partitioned Note. Concurrently, the Partitioned Note was exchanged for 197,122 shares of the Company’s common stock.”

Greenlane Holdings, Inc. entered into Sales Agreement with Yorkville Securities, LLC (effective 2026-01-07).

“On January 7, 2026, Greenlane Holdings, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Yorkville Securities, LLC (“Yorkville”) pursuant to which the Company may, from time to time, offer and sell shares (the “ATM Shares”) of its common stock, par value $0.01 per share (the “Common Stock”), through or to Yorkville, acting as sales agent or principal (the “ATM Offering”).”

AVITA Medical, Inc. terminated Existing Credit Agreement with Lender under existing facility (effective 2026-01-13).

“Simultaneously with the closing of the Initial Commitment Amount, the Company repaid in full and terminated all of its obligations and commitments (the “Refinancing Transaction”) under the Existing Credit Agreement (as defined below).”

AVITA Medical, Inc. entered into Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP valued at $60 million (effective 2026-01-13).

“On January 13, 2026 (the “Closing Date”), AVITA Medical, Inc. (the “Company”) entered into a Credit Agreement and Guaranty (the “Credit Agreement”) and a Security Agreement (the “Security Agreement”), by and among the Company, as borrower, Avita Medical Americas, LLC, a wholly-owned subsidiary of the Company, as guarantor (the “Guarantor,” taken together with the Company, the “Obligors”) and Perceptive Credit Holdings V, LP as a lender and the administrative agent (the “Lender,” and the “Administrative Agent,” as applicable).”

Momentus Inc. entered into Exchange Note with A.G.P./Alliance Global Partners valued at $500,000 (effective 2026-01-09).

“On January 9, 2026, Momentus exchanged the Original Note for a new unsecured convertible promissory note to A.G.P. (the “Exchange Note”) on substantially the same terms as the Original Note, including with respect to an aggregate principal amount of $500,000, but with a conversion price of $10.00 per share of Common Stock.”

Nexentis Technologies Inc. entered into Services Agreement with Voice Assist, Inc. valued at Company provides advisory services to Voice Assist in exchange for deferred cash consideration up to (effective 2026-01-13).

“The Company also entered into a Services Agreement with Voice Assist (the “Services Agreement”), pursuant to which the Company will provide non-exclusive general advisory, support, collaboration and related services to Voice Assist from time to time.”

Nexentis Technologies Inc. entered into Securities Exchange Agreement with Voice Assist, Inc. valued at transfer of approximately 98% of Save Foods ordinary shares to Voice Assist in exchange for 19.99% o (effective 2026-01-13).

“On January 13, 2026, N2OFF, Inc., a Nevada corporation (the “Company”), entered into a Securities Exchange Agreement (the “Agreement”) with Voice Assist, Inc., a public company incorporated under the laws of the State of Nevada (“Voice Assist”), and, for certain limited purposes set forth therein, Save Foods Ltd., a private company incorporated under the laws of the State of Israel and a majority-owned subsidiary of the Company (“Save Foods”, and together with the Company and Voice Assist, the “Parties”).”

Dogwood Therapeutics, Inc. terminated Equity Distribution Agreement (effective 2026-01-09).

“On January 9, 2026, Dogwood Therapeutics, Inc., a Delaware corporation (the “Company”) provided notice of its termination, effective January 9, 2026, of the Equity Distribution Agreement, dated November 28, 2025 (the “Northland Agreement")”

Dogwood Therapeutics, Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at approximately $12.5 million (effective 2026-01-11).

“On January 11, 2026, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”)”

Dogwood Therapeutics, Inc. entered into Registration Rights Agreement with the Investor (effective 2026-01-11).

“On January 11, 2026, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Investor”

Dogwood Therapeutics, Inc. entered into Purchase Agreement with a single institutional investor valued at approximately $12.5 million (effective 2026-01-11).

“On January 11, 2026, Dogwood Therapeutics, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with a single institutional investor named therein (the “Investor”) pursuant to which the Company agreed to sell and issue in a registered direct offering (the “Registered Offering”) to the Investor 2,338,948 shares of common stock”

Clene Inc. entered into Securities Purchase Agreement with certain institutional investors, existing stockholders of the Company, and certain of the Company's directors valued at $6.50 per unit (effective 2026-01-08).

“On January 8, 2026, Clene Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional investors, existing stockholders of the Company, and certain of the Company’s directors for the sale of (i) 928,333 shares of the Company’s common stock, par value $0.0001 per share (“common stock”), (ii) warrants to purchase up to 1,114,000 shares of the Company’s common stock (the “Series A Warrants”) and (iii) warrants to purchase up to 2,599,333 shares of the Company’s common stock (the “Series B Warrants,” and together with the Series A Warrants, the “Warrants”).”

GPGI, Inc. terminated Fourth Amended and Restated Credit Agreement with CompoSecure, L.L.C., Arculus Holdings, L.L.C., CompoSecure Holdings, L.L.C., Lenders, JPMorgan Chase Bank, N.A. valued at Repaid all loans and terminated all credit commitments outstanding under $330.0 million credit facil (effective 2026-01-13).

“Concurrently with the closing of the Transaction, the Company repaid all loans and terminated all credit commitments outstanding under that certain Fourth Amended and Restated Credit Agreement (the "Credit Agreement"), dated August 7, 2024, as amended by the Amendment No. 1 to Fourth Amended and Restated Credit Agreement and Limited Waiver, dated December 30, 2024, by and among CompoSecure, L.L.C., Arculus Holdings, L.L.C., CompoSecure Holdings, L.L.C., the Lenders (as defined therein) party thereto and JPMorgan Chase Bank, N.A., which provided for a credit facility of $330.0 million, comprising of a term loan of $200.0 million and a revolving credit facility of $130.0 million.”

GPGI, Inc. entered into Amendment to Amended and Restated Waiver Agreement with Resolute Compo Holdings LLC, Tungsten 2024 LLC valued at Board size increase to allow PE Holder nomination rights (effective 2026-01-13).

“In connection with the closing of the Transaction, on the Closing Date, Resolute Compo Holdings LLC, Tungsten 2024 LLC and the Company entered into an amendment (the "Amendment") to the Amended and Restated Waiver Agreement, dated as of July 12, 2025, between such parties, pursuant to which the parties agreed that in the event the Company Board rescinds the Board Size Requirement Waiver (as defined therein), the Company Board will adopt resolutions increasing the size of the Board to allow the PE Holder to continue to exercise its nomination rights under the Investor Rights Agreement.”

GPGI, Inc. entered into Management Agreement with Resolute Holdings Management, Inc. valued at Quarterly management fee equal to 2.5% of last 12 months' Adjusted EBITDA; ten-year term with automa (effective 2026-01-13).

“In connection with the closing of the Transaction, and pursuant to the terms of the existing Management Agreement, dated as of February 28, 2025, by and between Resolute Holdings and CompoSecure Holdings, L.L.C. (the "CompoSecure Management Agreement"), an indirect subsidiary of the Company that will hold, directly or indirectly, the business of Husky following the closing ("Husky Holdings"), entered into a management agreement (the "Management Agreement") with Resolute Holdings Management, Inc. ("Resolute Holdings") on the Closing Date.”

GPGI, Inc. entered into Registration Rights Agreement with PE Holder valued at Shelf registration statement; demand and piggy-back registration rights; indemnification (effective 2026-01-13).

“Pursuant to the terms of the terms of the Transaction Agreement, on the Closing Date, the Company entered into a Registration Rights Agreement (the "Registration Rights Agreement") with the PE Holder (collectively, with each other person who has executed and delivered a joinder thereto, the "RRA Parties") which, among other things, provides that the Company will as soon as practicable file with the SEC a shelf registration statement pursuant to Rule 415 under the Securities Act registering the resale of certain shares of the Common Stock and certain other equity securities of the Company held by the RRA Parties.”

GPGI, Inc. entered into Investor Rights Agreement with PE Titan CS Holdings L.P. valued at Right to nominate board members; lock-up of 90 days; freely pursue business opportunities (effective 2026-01-13).

“Pursuant to the terms of the Transaction Agreement, on the Closing Date, the Company entered into an Investor Rights Agreement (the "Investor Rights Agreement") with PE Titan CS Holdings L.P., an affiliate of Platinum (the "PE Holder").”

Offerpad Solutions Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners valued at 5.0% of aggregate gross proceeds from the sale of Shares; out-of-pocket expense reimbursement up to (effective 2026-01-11).

“On January 11, 2026, in connection with the foregoing transactions, the Company entered into a placement agency agreement (the “Placement Agreement”) with A.G.P./Alliance Global Partners (the “Placement Agent”) pursuant to which the Placement Agent served as the exclusive placement agent in connection with the Offering.”

Offerpad Solutions Inc. entered into Securities Purchase Agreement with Purchasers named therein valued at 10,000,000 shares of Class A common stock at $1.80 per share, gross proceeds of $18.0 million (effective 2026-01-11).

“On January 11, 2026, Offerpad Solutions Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (together, the “Purchasers”), providing for the issuance and sale by the Company of an aggregate of 10,000,000 shares (the “Shares”) of the Company’s Class A common stock, $0.0001 par value per share (the “Common Stock”).”

Intuitive Machines, Inc. entered into Stifel Waiver with Stifel Bank valued at Waiver in respect of Loan and Security Agreement dated March 4, 2025; Stifel Bank consented to Acqui (effective 2026-01-12).

“On January 12, 2026, the Company, Purchaser and Stifel Bank entered into a waiver (the “Stifel Waiver”), in respect of that certain Loan and Security Agreement, dated as of March 4, 2025, among such parties, pursuant to which Stifel Bank consented to the Acquisition while halting any borrowing and covenant obligations by the Company or Purchaser under such facility.”

Intuitive Machines, Inc. entered into Waiver, Consent, Amendment and Assignment Agreement of Orbital Receivables Purchase Facility with Lanteris Space LLC, Vantor Parent Inc., ING Belgium NV/SA valued at Purchaser became guarantor under Orbital Receivables Purchase Facility with maximum aggregate amount (effective 2026-01-13).

“On January 13, 2026, in connection with closing of the Acquisition, Purchaser entered into a Waiver, Consent, Amendment and Assignment Agreement (the “Waiver, Consent, Amendment and Assignment Agreement”), with Lanteris Space LLC (a subsidiary of Lanteris), as seller and servicer, Vantor Parent Inc. (an affiliate of Seller), as assignor and existing guarantor and ING Belgium NV/SA (“ING”), pursuant to which Purchaser became a guarantor under the Amended and Restated Receivables Purchase Agreement dated as of December 1, 2023 (as amended by that certain Omnibus Amendment dated as of May 21, 2024 among Lanteris, Seller and ING, and as further amended, amended and restated, supplemented or otherwise modified from time to time, the “Orbital Receivables Purchase Facility”).”

Intuitive Machines, Inc. entered into Registration Rights Agreement with Seller valued at Registration rights including right to initiate up to three underwritten public offerings and piggyb (effective 2026-01-13).

“On January 13, 2026, the Company entered into a registration rights agreement with Seller, pursuant to which Seller received certain registration rights, including the right to initiate up to three underwritten public offerings, and piggyback registration rights relating to the Stock Consideration.”

Lomond Therapeutics Holdings, Inc. terminated License Agreement with Bala Therapeutics, Inc. valued at Terminated agreement with consideration including shares representing 3.5% fully diluted capitalizat (effective 2026-01-07).

“On January 7, 2026, Lomond Therapeutics, Inc. (the "Company") entered into a Termination Agreement with Bala Therapeutics, Inc. ("Bala"), pursuant to which that certain License Agreement, dated October 17, 2024, by and between the Company and Bala (the "License Agreement"), was terminated ab initio , effective immediately.”

Lomond Therapeutics Holdings, Inc. entered into Amended and Restated Limited Liability Company Agreement with Idwal Therapeutics, LLC (effective 2026-01-08).

“greement”) and related Amended and Restated Limited Liability Company Agreement (the “A&R LLC Agreement”) as an investor in Idwal Therapeutics, LLC (“Idwal”).”